Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (361-370 of 471) with videos related to

Pageof 48
Sort By:
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2018
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative DisordersLarissa Higgins, Samih H Nasr, Samar M Said, et al.
Blood Advances|October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Blood Cancer Journal|December 13, 2018
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcomeAshley R Paquin, Shaji K Kumar, Francis K Buadi, et al.
Blood Cancer Journal|May 13, 2020
Venetoclax for the treatment of translocation (11;14) AL amyloidosisM Hasib Sidiqi, Abdullah S Al Saleh, Nelson Leung, et al.
American Journal of Hematology|September 9, 2018
Utility and prognostic value of <sup>18</sup> F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Francis K Buadi, et al.
Blood|March 28, 2009
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasonePrashant Kapoor, Shaji Kumar, Rafael Fonseca, et al.
Leukemia|July 31, 2020
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Pageof 48

Showing results (361-370 of 471) with videos related to

Sort By:
Pageof 48
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Blood|October 23, 2013
Smoldering multiple myeloma requiring treatment: time for a new definition?Angela Dispenzieri, A Keith Stewart, Asher Chanan-Khan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2018
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative DisordersLarissa Higgins, Samih H Nasr, Samar M Said, et al.
Blood Advances|October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 13, 2017
Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosisNidhi Tandon, Surbhi Sidana, S Vincent Rajkumar, et al.
Blood Cancer Journal|December 13, 2018
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcomeAshley R Paquin, Shaji K Kumar, Francis K Buadi, et al.
Blood Cancer Journal|May 13, 2020
Venetoclax for the treatment of translocation (11;14) AL amyloidosisM Hasib Sidiqi, Abdullah S Al Saleh, Nelson Leung, et al.
American Journal of Hematology|September 9, 2018
Utility and prognostic value of <sup>18</sup> F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Francis K Buadi, et al.
Blood|March 28, 2009
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasonePrashant Kapoor, Shaji Kumar, Rafael Fonseca, et al.
Leukemia|July 31, 2020
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Pageof 48